Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

China · Delayed Price · Currency is CNY

28.76

+0.75 (2.68%)

Sep 21, 2026, 3:00 PM CST

Market Cap	13.13B -7.6%
Revenue (ttm)	5.92B -6.1%
Net Income	101.76M
EPS	0.22
Shares Out	456.64M
PE Ratio	131.31
Forward PE	29.20
Dividend	0.88 (3.06%)
Ex-Dividend Date	Feb 5, 2026

Volume	12,957,071
Open	27.99
Previous Close	28.01
Day's Range	27.99 - 29.14
52-Week Range	21.50 - 40.68
Beta	0.37
Analysts	Buy
Price Target	31.19 (+8.45%)
Earnings Date	Aug 25, 2026

About SHA:603882

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides medical health check-up, medical cold chain logistics, and other services, as well as sells diagnostic products. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2006

Employees 9,529

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603882

Full Company Profile

Financial Performance

In 2025, SHA:603882's revenue was 6.03 billion, a decrease of -16.12% compared to the previous year's 7.19 billion. Losses were -173.24 million, -54.56% less than in 2024.

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for 603882 stock is "Buy." The 12-month stock price target is ¥31.19, which is an increase of 8.45% from the latest price.

Price Target

¥31.19

(8.45% upside)

Analyst Consensus: Buy

Stock Forecasts